For head and neck cancer, Garcia -Carracedo et al. 12 reported a positive correlation between the mTOR activation and a less aggressive phenotype, resulting in a significantly improved survival in patients with laryngeal cancer. This evidence concerns the gene MTOR and head and neck cancer.